{
      "ptx_code": "PTX151",
      "chem_name": "Droperidol",
      "casrn": "548-73-2",
      "dtxsid": "DTXSID6022973",
      "smiles": "FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12",
      "inchikey": "RMEDXOLNCUSCGS-UHFFFAOYSA-N",
      "label": "PTX151 | Droperidol",
      "drugbank_id": "DB00450",
      "use_class": "Pharmaceutical",
      "tox_class": "Cardiotoxicity; Hepatotoxicity",
      "chem_name_user": "Droperidol",
      "mw_g_mol": "379.44",
      "solubility_h2o_mol_liter": "2.10e-05",
      "source_solubility_h2o": "COMPTOX (OPERA)",
      "henry_coefficient_atm_m3_mol": "1.76e-10",
      "source_henry": "COMPTOX",
      "log_kaw_kh_rt": "8.14",
      "source_kaw": "LSER",
      "pka_acid": "12.49",
      "pka_base": "8.01",
      "source_pka": "UFZ; Sirius T3",
      "log_kow_liter_liter": "3.50",
      "source_kow": "PhysPropNCCT (COMPTOX)",
      "log_dlipw_ph74_liter_liter": "3.10",
      "source_dlipw": "klipW (?mw = 1)",
      "freely_dissolved_fraction": "0.29",
      "density_kg_liter": "1.31",
      "source_density": "COMPTOX",
      "average_mass": "379.44",
      "boiling_point": "",
      "source_boiling_point": "",
      "melting_point": "145.75 \u00b0C",
      "source_melting_point": "Jean-Claude Bradley Open Melting Point Dataset",
      "vapor_pressure": "",
      "source_vapor_pressure": "",
      "baseline_drerio": "142.00",
      "baseline_dmagna": "97.80",
      "baseline_celegans": "214.86",
      "baseline_xlaevis": "98.93",
      "baseline_dmelanogaster": "845.15",
      "baseline_cells": "7.26e-05",
      "baseline_cells_generic_micromole_liter_free_ec10": "2.07e-05",
      "moa_drugbank": "The exact mechanism of action is unknown, however, droperidol causes a CNS depression at subcortical levels of the brain, midbrain, and brainstem reticular formation. It may antagonize the actions of glutamic acid within the extrapyramidal system. It may also inhibit cathecolamine receptors and the reuptake of neurotransmiters and has strong central antidopaminergic action and weak central anticholinergic action. It can also produce ganglionic blockade and reduced affective response. The main actions seem to stem from its potent Dopamine(2) receptor antagonism with minor antagonistic effects on alpha-1 adrenergic receptors as well.",
      "protein_binding": "",
      "moa_t3db": "",
      "aop": [],
      "targets": []
}